Ventilator-Associated Events 5 Years Later

References

1. 1.↵
   1. Klompas M,
   2. Platt R

   . Ventilator-associated pneumonia–the wrong quality measure for benchmarking. Ann Intern Med 2007;147(11):803–805.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Magill SS,
   2. Klompas M,
   3. Balk R,
   4. Burns SM,
   5. Deutschman CS,
   6. Diekema D,
   7. et al

   . Developing a new, national approach to surveillance for ventilator-associated events. Crit Care Med 2013;41(11):2467–2475.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Magill SS,
   2. Li Q,
   3. Gross C,
   4. Dudeck M,
   5. Allen-Bridson K,
   6. Edwards JR

   . Incidence and characteristics of ventilator-associated events reported to the National Healthcare Safety Network in 2014. Crit Care Med 2016;44(12):2154–2162.

   OpenUrl
4. 4.↵
   1. Kobayashi H,
   2. Uchino S,
   3. Takinami M,
   4. Uezono S

   . The impact of ventilator-associated events in critically ill subjects with prolonged mechanical ventilation. Respir Care 2017;62(11):1379–1386.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Klompas M,
   2. Khan Y,
   3. Kleinman K,
   4. Evans RS,
   5. Lloyd JF,
   6. Stevenson K,
   7. et al

   . Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One 2011;6(3):e18062.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Muscedere J,
   2. Sinuff T,
   3. Heyland DK,
   4. Dodek PM,
   5. Keenan SP,
   6. Wood G,
   7. et al

   . The clinical impact and preventability of ventilator-associated conditions in critically ill mechanically ventilated patients. Chest 2013;144(5):1453–1460.

   OpenUrlCrossRefPubMed
7. 7.
   1. Klein Klouwenberg PM,
   2. van Mourik MS,
   3. Ong DS,
   4. Horn J,
   5. Schultz MJ,
   6. Cremer OL,
   7. et al

   . Electronic implementation of a novel surveillance paradigm for ventilator-associated events: feasibility and validation. Am J Respir Crit Care Med 2014;189(8):947–955.

   OpenUrlCrossRefPubMed
8. 8.
   1. Chang HC,
   2. Kung SC,
   3. Wang CM,
   4. Liu WL

   . Discordance between novel and traditional surveillance paradigm of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2014;35(9):1195–1196.

   OpenUrlPubMed
9. 9.↵
   1. Bouadma L,
   2. Sonneville R,
   3. Garrouste-Orgeas M,
   4. Darmon M,
   5. Souweine B,
   6. Voiriot G,
   7. et al

   . Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med 2015;43(9):1798–1806.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Nussenblatt V,
    2. Avdic E,
    3. Berenholtz S,
    4. Daugherty E,
    5. Hadhazy E,
    6. Lipsett PA,
    7. et al

    . Ventilator-associated pneumonia: overdiagnosis and treatment are common in medical and surgical intensive care units. Infect Control Hosp Epidemiol 2014;35(3):278–284.

    OpenUrlPubMed
11. 11.↵
    1. Esperatti M,
    2. Ferrer M,
    3. Giunta V,
    4. Ranzani OT,
    5. Saucedo LM,
    6. Li Bassi G,
    7. et al

    . Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med 2013;41(9):2151–2161.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.
    1. Klompas M,
    2. Magill S,
    3. Robicsek A,
    4. Strymish JM,
    5. Kleinman K,
    6. Evans RS,
    7. et al

    . Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med 2012;40(12):3154–3161.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Klompas M,
    2. Li L,
    3. Menchaca JT,
    4. Gruber S

    , Centers for Disease Control and Prevention Epicenters Program. Ultra-short-course antibiotics for patients with suspected ventilator-associated pneumonia but minimal and stable ventilator settings. Clin Infect Dis 2017;64(7):870–876.

    OpenUrl
14. 14.↵
    1. Klompas M

    . Eight initiatives that misleadingly lower ventilator-associated pneumonia rates. Am J Infect Control 2012;40(5):408–410.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Metersky ML,
    2. Wang Y,
    3. Klompas M,
    4. Eckenrode S,
    5. Bakullari A,
    6. Eldridge N

    . Trend in ventilator-associated pneumonia rates between 2005 and 2013 JAMA 2016;316(22):2427–2429.

    OpenUrl
16. 16.↵
    1. Klompas M,
    2. Speck K,
    3. Howell MD,
    4. Greene LR,
    5. Berenholtz SM

    . Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 2014;174(5):751–761.

    OpenUrlCrossRefPubMed
17. 17.
    1. Price R,
    2. MacLennan G,
    3. Glen J

    . Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014;348:g2197.

    OpenUrlAbstract/FREE Full Text
18. 18.
    1. Klompas M

    . Oropharyngeal decontamination with antiseptics to prevent ventilator-associated pneumonia: rethinking the benefits of chlorhexidine. Semin Respir Crit Care Med 2017;38(3):381–390.

    OpenUrl
19. 19.↵
    1. Klompas M,
    2. Li L,
    3. Kleinman K,
    4. Szumita PM,
    5. Massaro AF

    . Associations between ventilator bundle components and outcomes. JAMA Intern Med 2016;176(9):1277–1283.

    OpenUrl
20. 20.
    1. Sasabuchi Y,
    2. Matsui H,
    3. Lefor AK,
    4. Fushimi K,
    5. Yasunaga H

    . Risks and benefits of stress ulcer prophylaxis for patients with severe sepsis. Crit Care Med 2016;44(7):e464–e469.

    OpenUrl
21. 21.↵
    1. Alhazzani W,
    2. Guyatt G,
    3. Alshahrani M,
    4. Deane AM,
    5. Marshall JC,
    6. Hall R,
    7. et al

    . Withholding pantoprazole for stress ulcer prophylaxis in critically ill patients: a pilot randomized clinical trial and meta-analysis. Crit Care Med 2017;45(7):1121–1129.

    OpenUrl
22. 22.↵
    1. Lewis SC,
    2. Li L,
    3. Murphy MV,
    4. Klompas M

    . Risk factors for ventilator-associated events: a case-control multivariable analysis. Crit Care Med 2014;42(8):1839–1848.

    OpenUrlPubMed
23. 23.
    1. Cocoros NM,
    2. Priebe G,
    3. Gray JE,
    4. Toltzis P,
    5. Larsen GY,
    6. Logan LK,
    7. et al

    . Factors associated with pediatric ventilator-associated conditions in six U.S. hospitals: a nested case-control study. Pediatr Crit Care Med 2017. doi: 10.1097/PCC.0000000000001328.
24. 24.
    1. Ogbu OC,
    2. Martin GS,
    3. Sevransky JE,
    4. Murphy DJ

    . High tidal volumes are independently associated with development of a ventilator-associated condition in the ICU. Am J Respir Crit Care Med 2015;191:A3117.

    OpenUrl
25. 25.↵
    1. Klompas M,
    2. Li L,
    3. Szumita P,
    4. Kleinman K,
    5. Murphy MV

    , CDC Prevention Epicenters Program. Associations between different sedatives and ventilator-associated events, length of stay, and mortality in patients who were mechanically ventilated. Chest 2016;149(6):1373–1379.

    OpenUrl
26. 26.↵
    1. Klompas M

    . Potential strategies to prevent ventilator-associated events. Am J Respir Crit Care Med 2015;192(12):1420–1430.

    OpenUrlPubMed
27. 27.↵
    1. Frat JP,
    2. Thille AW,
    3. Mercat A,
    4. Girault C,
    5. Ragot S,
    6. Perbet S,
    7. et al

    . High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185–2196.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Osadnik CR,
    2. Tee VS,
    3. Carson-Chahhoud KV,
    4. Picot J,
    5. Wedzicha JA,
    6. Smith BJ

    . Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017;(7):CD004104.
29. 29.↵
    1. Strøm T,
    2. Martinussen T,
    3. Toft P

    . A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010;375(9713):475–480.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.
    1. Girard TD,
    2. Kress JP,
    3. Fuchs BD,
    4. Thomason JW,
    5. Schweickert WD,
    6. Pun BT,
    7. et al

    . Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008;371(9607):126–134.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Schweickert WD,
    2. Pohlman MC,
    3. Pohlman AS,
    4. Nigos C,
    5. Pawlik AJ,
    6. Esbrook CL,
    7. et al

    . Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373(9678):1874–1882.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.↵
    1. Wang L,
    2. Li X,
    3. Yang Z,
    4. Tang X,
    5. Yuan Q,
    6. Deng L,
    7. et al

    . Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation. Cochrane Database Syst Rev 2016;(1):CD009946.
33. 33.
    1. Mekontso Dessap A,
    2. Roche-Campo F,
    3. Kouatchet A,
    4. Tomicic V,
    5. Beduneau G,
    6. Sonneville R,
    7. et al

    . Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med 2012;186(12):1256–1263.

    OpenUrlCrossRefPubMed
34. 34.
    1. Hébert PC,
    2. Wells G,
    3. Blajchman MA,
    4. Marshall J,
    5. Martin C,
    6. Pagliarello G,
    7. et al

    . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340(6):409–417.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Yadav H,
    2. Thompson BT,
    3. Gajic O

    . Fifty years of research in ARDS: is acute respiratory distress syndrome a preventable disease? Am J Respir Crit Care Med 2017;195(6):725–736.

    OpenUrl
36. 36.↵
    1. Barnes-Daly MA,
    2. Phillips G,
    3. Ely EW

    . Improving hospital survival and reducing brain dysfunction at seven California community hospitals: implementing PAD guidelines via the ABCDEF bundle in 6,064 patients. Crit Care Med 2017;45(2):171–178.

    OpenUrl
37. 37.
    1. Rhodes A,
    2. Evans LE,
    3. Alhazzani W,
    4. Levy MM,
    5. Antonelli M,
    6. Ferrer R,
    7. et al

    . Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017;45(3):486–552.

    OpenUrl
38. 38.↵
    1. Klompas M,
    2. Branson R,
    3. Eichenwald EC,
    4. Greene LR,
    5. Howell MD,
    6. Lee G,
    7. et al

    . Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35(8):915–936.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Klompas M,
    2. Anderson D,
    3. Trick W,
    4. Babcock H,
    5. Kerlin MP,
    6. Li L,
    7. et al

    . The preventability of ventilator-associated events: the CDC Prevention Epicenters Wake Up and Breathe Collaborative. Am J Respir Crit Care Med 2015;191(3):292–301.

    OpenUrlCrossRefPubMed
40. 40.
    1. Mekontso Dessap A,
    2. Katsahian S,
    3. Roche-Campo F,
    4. Varet H,
    5. Kouatchet A,
    6. Tomicic V,
    7. et al

    . Ventilator-associated pneumonia during weaning from mechanical ventilation: role of fluid management. Chest 2014;146(1):58–65.

    OpenUrlPubMed
41. 41.↵
    1. Rawat N,
    2. Yang T,
    3. Ali KJ,
    4. Catanzaro M,
    5. Cohen MD,
    6. Farley DO,
    7. et al

    . Two-state collaborative study of a multifaceted intervention to decrease ventilator-associated events. Crit Care Med 2017;45(7):1208–1215.

    OpenUrl